Flu Scare Yields Vaccine Makers $450 Million in Added Profits

march 3, 2004  11:36 am
Flu Scare Yields Vaccine Makers $450 Million in Added Profits
Warnings of a "killer" flu strain that led Americans to be inoculated in record numbers last fall were overblown hype, Tara Servatius reports in Creative Loafing Charlotte. The experts who drove the story "either worked directly for the flu vaccine companies or served on the boards of special interest groups whose activities those companies funded," she writes. Not only was there no remarkable epidemic, but studies show the sought-after vaccine was only 14 percent effective in preventing the illness.